These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23468111)

  • 1. CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis.
    Arora P; Foster EL; Porcelli SA
    Adv Exp Med Biol; 2013; 783():199-223. PubMed ID: 23468111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
    Ulrichs T; Porcelli SA
    Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
    Zajonc DM; Kronenberg M
    Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.
    Venkataswamy MM; Baena A; Goldberg MF; Bricard G; Im JS; Chan J; Reddington F; Besra GS; Jacobs WR; Porcelli SA
    J Immunol; 2009 Aug; 183(3):1644-56. PubMed ID: 19620317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scavenger receptors target glycolipids for natural killer T cell activation.
    Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
    J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
    Venkataswamy MM; Porcelli SA
    Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1a, CD1b, and CD1c in immunity against mycobacteria.
    Van Rhijn I; Ly D; Moody DB
    Adv Exp Med Biol; 2013; 783():181-97. PubMed ID: 23468110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection.
    Ulrichs T; Moody DB; Grant E; Kaufmann SH; Porcelli SA
    Infect Immun; 2003 Jun; 71(6):3076-87. PubMed ID: 12761085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
    Kronenberg M
    J Vis Exp; 2007; (10):635. PubMed ID: 18989407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharides and glycolipids of Mycobacterium tuberculosis and their induced immune responses.
    Gong Y; Wang J; Li F; Zhu B
    Scand J Immunol; 2023 May; 97(5):e13261. PubMed ID: 39008002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1 and mycobacterial lipids activate human T cells.
    Van Rhijn I; Moody DB
    Immunol Rev; 2015 Mar; 264(1):138-53. PubMed ID: 25703557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
    Fischer K; Scotet E; Niemeyer M; Koebernick H; Zerrahn J; Maillet S; Hurwitz R; Kursar M; Bonneville M; Kaufmann SH; Schaible UE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10685-90. PubMed ID: 15243159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
    Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
    Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
    Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.
    Pei B; Vela JL; Zajonc D; Kronenberg M
    Ann N Y Acad Sci; 2012 Apr; 1253(1):68-79. PubMed ID: 22352829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.